We basically said if these companies are selling things like insulin and they are jacking up the prices again and again and again, which they have, they basically have to make rebates if they ever raise prices above inflation.
Wyden discusses a bipartisan bill to combat pharmaceutical price gouging.
Share
More from Ron Wyden
More importantly, independent privacy and security oversight is not an optional expense to be cut when it becomes inconvenient.
extremely dangerous to give Trump massive new tariff powers, particularly after we've seen the disastrous impacts of his corrupt, chaotic, and inflationary tariff spree,"
If Congress passes this bill, members will be condoning the tariff chaos of the last year and a half – and inviting more.
We strongly urge BLM to reject this proposed rescission and maintain the 2024 Waste Prevention rule.
Other voices in this conversation
